INVION LIMITED - Announcements

4.17%

10.0¢

Market Cap $8.541M

Healthcare Biotechnology

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IVX	Phase 2 data presented to American Thoracic Society-IVX.AX	PRICE SENSITIVE	20/05/16	256.11KB	Share
IVX	Response to ASX Appendix 4C Query-IVX.AX	PRICE SENSITIVE	09/05/16	360.01KB	Share
IVX	Appendix 4C - quarterly-IVX.AX	PRICE SENSITIVE	29/04/16	262.46KB	Share
IVX	End of Phase 2 Meeting for INV102 (nadolol)-IVX.AX	PRICE SENSITIVE	04/04/16	263.1KB	Share
IVX	Smoking cessation patent allowance and Operational update	PRICE SENSITIVE	10/03/16	254.66KB	Share
IVX	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	26/02/16	569.05KB	Share
IVX	Final Director's Interest Notice		01/02/16	193.17KB	Share
IVX	Changes to Board structure		01/02/16	262.89KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/16	374.65KB	Share
IVX	Cleansing Notice under S708A Corporations Act		27/01/16	224.37KB	Share
IVX	Appendix 3B - conversion of convertible security		27/01/16	556.07KB	Share
IVX	Cleansing Notice under S 708A Corporations Act		07/01/16	224.36KB	Share
IVX	Appendix 3B		07/01/16	556.29KB	Share
IVX	Notice under S708A Corporations Act		17/12/15	225.33KB	Share
IVX	Appendix 3B		17/12/15	560.88KB	Share
IVX	Change of Director's Interest Notice - Mr Heading		11/12/15	286.93KB	Share
IVX	Change of Director's Interest Notice - Dr Collier		11/12/15	292.88KB	Share
IVX	Change of Director's Interest Notice - Dr Glass		11/12/15	293.04KB	Share
IVX	Change of Director's Interest Notice - Dr Campbell		11/12/15	292.23KB	Share
IVX	Additional Placement details as required by LR 3.10.5A		10/12/15	225.52KB	Share
IVX	Notice under section 708A Corporations Act		10/12/15	241.5KB	Share
IVX	Appendix 3B - SPP and Placement securities		10/12/15	556.82KB	Share
IVX	Allottment of SPP and Placement shares complete		10/12/15	233.96KB	Share
IVX	Invion completes SPP and Placement	PRICE SENSITIVE	09/12/15	237.42KB	Share
IVX	SPP subscriptions update		03/12/15	232.63KB	Share
IVX	Extension of SPP closing date to 7 December 2015		27/11/15	231.2KB	Share
IVX	Investor newsletter		25/11/15	541.12KB	Share
IVX	Results of Annual General Meeting		18/11/15	239.77KB	Share
IVX	Chairman's Address and CEO presentaiton to AGM		18/11/15	3.52MB	Share
IVX	Smoking cessation trial results of ongoing data analysis	PRICE SENSITIVE	17/11/15	239.02KB	Share
IVX	Share Purchase Plan Cleansing Notice		10/11/15	225.84KB	Share
IVX	Letter to shareholders SPP rules and sample application		10/11/15	888.85KB	Share
IVX	Invion announces Share Purchase Plan	PRICE SENSITIVE	10/11/15	230.95KB	Share
IVX	Corporate presentation November 2015		10/11/15	3.24MB	Share
IVX	Litigation update - decision of High Court	PRICE SENSITIVE	04/11/15	108.89KB	Share
IVX	Completion of enrolment in INV102 phase II asthma study	PRICE SENSITIVE	02/11/15	231.52KB	Share
IVX	Appendix 4G - key to corporate governance disclosures		30/10/15	254.33KB	Share
IVX	Corporate Governance Statement		30/10/15	329.7KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	252.26KB	Share
IVX	AGM Notice of Meeting and sample proxy form		16/10/15	538.88KB	Share
IVX	Receipt of R&D tax rebate and repayment of Metamor loan	PRICE SENSITIVE	09/10/15	229.39KB	Share
IVX	Dr Glass discusses P2 smoking cessation trial results		06/10/15	243.75KB	Share
IVX	Invion - successful completion of P2 study of INV102	PRICE SENSITIVE	05/10/15	245.24KB	Share
IVX	Corporate Presentation - September 2015		07/09/15	1.92MB	Share
IVX	Invion announces no secondary capital raise	PRICE SENSITIVE	07/09/15	227.63KB	Share
IVX	Notice under s708A Corporations Act - cleasning notice		03/09/15	253.97KB	Share
IVX	Placement - information required under LR3.10.5A		03/09/15	242.69KB	Share
IVX	Appendix 3B - issue of placement shares and options		03/09/15	563.13KB	Share
IVX	Notice under section 708A Corporations Act		01/09/15	255.31KB	Share
IVX	Invion completes placement to institutional US investor	PRICE SENSITIVE	01/09/15	263.25KB	Share
IVX	Appendix 4E and Financial Report for YE 30 June 15	PRICE SENSITIVE	31/08/15	1.18MB	Share
IVX	Trading Halt	PRICE SENSITIVE	28/08/15	224.65KB	Share
IVX	Dr Glass discusses phase II lupus data with BRR		18/08/15	243.32KB	Share
IVX	INV103 ala-Cpn10 clinical trial in lupus complete	PRICE SENSITIVE	17/08/15	284.78KB	Share
IVX	Response to ASX Appendix 4C Query	PRICE SENSITIVE	11/08/15	320.53KB	Share
IVX	Corporate presentation - August 2015		06/08/15	2.05MB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	368.36KB	Share
IVX	INV104 (zafirlukast) presentation - status and milestones		27/07/15	586.57KB	Share
IVX	Joint development and licensing agreement for Zafirlukast	PRICE SENSITIVE	27/07/15	292.84KB	Share
IVX	Response to Price Query	PRICE SENSITIVE	13/07/15	327.6KB	Share
IVX	Milestone update	PRICE SENSITIVE	03/07/15	236.37KB	Share
IVX	PhII smoking cessation - dosing complete analysis underway	PRICE SENSITIVE	29/06/15	346.96KB	Share
IVX	Appendix 3B - lapse of unlisted share options		19/06/15	499.73KB	Share
IVX	Appendix 3B - lapse of options issued under ESOP		17/06/15	500.3KB	Share
IVX	INV102 (nadolol) presentation - status and milestones		16/06/15	1.06MB	Share
IVX	Litigation update - Decision of Court of Appeal		12/06/15	228.81KB	Share
IVX	Cleansing Notice - unlisted share options		28/05/15	214.62KB	Share
IVX	Appendix 3B - unlisted share options to employees		28/05/15	501.5KB	Share
IVX	Results of General Meeting		25/05/15	98.97KB	Share
IVX	Drs Glass and Castro discuss data presented to ATS		19/05/15	232.79KB	Share
IVX	Oral nadolol data presented to American Thoracic Society	PRICE SENSITIVE	19/05/15	241.73KB	Share
IVX	Appendix 3B - correction to Rights Issue allotment number		11/05/15	768.95KB	Share
IVX	Ceasing to be a substantial holder		04/05/15	45.34KB	Share
IVX	Change in substantial holding		01/05/15	101.31KB	Share
IVX	Appendix 4C - quarterly		29/04/15	229.42KB	Share
IVX	Final Directors Interest Notice - Dr Ralph Craven		29/04/15	187.42KB	Share
IVX	Invion appoints Mr Brett Heading as Chairman		29/04/15	221.96KB	Share
IVX	Appendix 3Y - R Craven		28/04/15	281.83KB	Share
IVX	Appendix 3Y - G Collier		28/04/15	283.32KB	Share
IVX	Appendix 3Y - B Heading		28/04/15	282.86KB	Share
IVX	Placement cleansing notice		27/04/15	229.63KB	Share
IVX	Appendix 3B - Placement		27/04/15	506.26KB	Share
IVX	Notice of General Meeting and sample Proxy Form (2)		24/04/15	771.49KB	Share
IVX	Notice of General Meeting and sample Proxy Form (1)		24/04/15	705.07KB	Share
IVX	Appendix 3B - Rights Issue new shares		24/04/15	506.23KB	Share
IVX	Placement - additional information perLR 3.10.5A		22/04/15	211.78KB	Share
IVX	Rights Issue fully subscribed- correction to issue price		22/04/15	228.22KB	Share
IVX	Rights Issue fully subscribed		22/04/15	223.82KB	Share
IVX	Rights Issue - short term BPAY code error and correction		16/04/15	215.84KB	Share
IVX	Entitlement Offer - Notice of despatch		30/03/15	213.85KB	Share
IVX	Entitlement offer - Letter to ineligible shareholders		30/03/15	254.09KB	Share
IVX	Placement cleansing notice		27/03/15	229.92KB	Share
IVX	Appendix 3B - Placement shares		27/03/15	505.25KB	Share
IVX	Change in substantial holding		26/03/15	104.43KB	Share
IVX	Appendix 3B		24/03/15	508.17KB	Share
IVX	Pre-IND status for inhaled INV102 (nadolol)	PRICE SENSITIVE	23/03/15	242.11KB	Share
IVX	Pre-IND status for inhaled INV102 (nadolol)	PRICE SENSITIVE	23/03/15	242.11KB	Share
IVX	Letter to eligible shareholders		20/03/15	274.59KB	Share
IVX	Letter to option holders		20/03/15	221.14KB	Share
IVX	Entitlment offer information booklet	PRICE SENSITIVE	20/03/15	2.63MB	Share

IVX Phase 2 data presented to American Thoracic Society-IVX.AX
20/05/16	PRICE SENSITIVE	256.11KB	Share
IVX Response to ASX Appendix 4C Query-IVX.AX
09/05/16	PRICE SENSITIVE	360.01KB	Share
IVX Appendix 4C - quarterly-IVX.AX
29/04/16	PRICE SENSITIVE	262.46KB	Share
IVX End of Phase 2 Meeting for INV102 (nadolol)-IVX.AX
04/04/16	PRICE SENSITIVE	263.1KB	Share
IVX Smoking cessation patent allowance and Operational update
10/03/16	PRICE SENSITIVE	254.66KB	Share
IVX Appendix 4D and Half Year Accounts
26/02/16	PRICE SENSITIVE	569.05KB	Share
IVX Final Director's Interest Notice
01/02/16		193.17KB	Share
IVX Changes to Board structure
01/02/16		262.89KB	Share
IVX Appendix 4C - quarterly
28/01/16	PRICE SENSITIVE	374.65KB	Share
IVX Cleansing Notice under S708A Corporations Act
27/01/16		224.37KB	Share
IVX Appendix 3B - conversion of convertible security
27/01/16		556.07KB	Share
IVX Cleansing Notice under S 708A Corporations Act
07/01/16		224.36KB	Share
IVX Appendix 3B
07/01/16		556.29KB	Share
IVX Notice under S708A Corporations Act
17/12/15		225.33KB	Share
IVX Appendix 3B
17/12/15		560.88KB	Share
IVX Change of Director's Interest Notice - Mr Heading
11/12/15		286.93KB	Share
IVX Change of Director's Interest Notice - Dr Collier
11/12/15		292.88KB	Share
IVX Change of Director's Interest Notice - Dr Glass
11/12/15		293.04KB	Share
IVX Change of Director's Interest Notice - Dr Campbell
11/12/15		292.23KB	Share
IVX Additional Placement details as required by LR 3.10.5A
10/12/15		225.52KB	Share
IVX Notice under section 708A Corporations Act
10/12/15		241.5KB	Share
IVX Appendix 3B - SPP and Placement securities
10/12/15		556.82KB	Share
IVX Allottment of SPP and Placement shares complete
10/12/15		233.96KB	Share
IVX Invion completes SPP and Placement
09/12/15	PRICE SENSITIVE	237.42KB	Share
IVX SPP subscriptions update
03/12/15		232.63KB	Share
IVX Extension of SPP closing date to 7 December 2015
27/11/15		231.2KB	Share
IVX Investor newsletter
25/11/15		541.12KB	Share
IVX Results of Annual General Meeting
18/11/15		239.77KB	Share
IVX Chairman's Address and CEO presentaiton to AGM
18/11/15		3.52MB	Share
IVX Smoking cessation trial results of ongoing data analysis
17/11/15	PRICE SENSITIVE	239.02KB	Share
IVX Share Purchase Plan Cleansing Notice
10/11/15		225.84KB	Share
IVX Letter to shareholders SPP rules and sample application
10/11/15		888.85KB	Share
IVX Invion announces Share Purchase Plan
10/11/15	PRICE SENSITIVE	230.95KB	Share
IVX Corporate presentation November 2015
10/11/15		3.24MB	Share
IVX Litigation update - decision of High Court
04/11/15	PRICE SENSITIVE	108.89KB	Share
IVX Completion of enrolment in INV102 phase II asthma study
02/11/15	PRICE SENSITIVE	231.52KB	Share
IVX Appendix 4G - key to corporate governance disclosures
30/10/15		254.33KB	Share
IVX Corporate Governance Statement
30/10/15		329.7KB	Share
IVX Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	252.26KB	Share
IVX AGM Notice of Meeting and sample proxy form
16/10/15		538.88KB	Share
IVX Receipt of R&D tax rebate and repayment of Metamor loan
09/10/15	PRICE SENSITIVE	229.39KB	Share
IVX Dr Glass discusses P2 smoking cessation trial results
06/10/15		243.75KB	Share
IVX Invion - successful completion of P2 study of INV102
05/10/15	PRICE SENSITIVE	245.24KB	Share
IVX Corporate Presentation - September 2015
07/09/15		1.92MB	Share
IVX Invion announces no secondary capital raise
07/09/15	PRICE SENSITIVE	227.63KB	Share
IVX Notice under s708A Corporations Act - cleasning notice
03/09/15		253.97KB	Share
IVX Placement - information required under LR3.10.5A
03/09/15		242.69KB	Share
IVX Appendix 3B - issue of placement shares and options
03/09/15		563.13KB	Share
IVX Notice under section 708A Corporations Act
01/09/15		255.31KB	Share
IVX Invion completes placement to institutional US investor
01/09/15	PRICE SENSITIVE	263.25KB	Share
IVX Appendix 4E and Financial Report for YE 30 June 15
31/08/15	PRICE SENSITIVE	1.18MB	Share
IVX Trading Halt
28/08/15	PRICE SENSITIVE	224.65KB	Share
IVX Dr Glass discusses phase II lupus data with BRR
18/08/15		243.32KB	Share
IVX INV103 ala-Cpn10 clinical trial in lupus complete
17/08/15	PRICE SENSITIVE	284.78KB	Share
IVX Response to ASX Appendix 4C Query
11/08/15	PRICE SENSITIVE	320.53KB	Share
IVX Corporate presentation - August 2015
06/08/15		2.05MB	Share
IVX Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	368.36KB	Share
IVX INV104 (zafirlukast) presentation - status and milestones
27/07/15		586.57KB	Share
IVX Joint development and licensing agreement for Zafirlukast
27/07/15	PRICE SENSITIVE	292.84KB	Share
IVX Response to Price Query
13/07/15	PRICE SENSITIVE	327.6KB	Share
IVX Milestone update
03/07/15	PRICE SENSITIVE	236.37KB	Share
IVX PhII smoking cessation - dosing complete analysis underway
29/06/15	PRICE SENSITIVE	346.96KB	Share
IVX Appendix 3B - lapse of unlisted share options
19/06/15		499.73KB	Share
IVX Appendix 3B - lapse of options issued under ESOP
17/06/15		500.3KB	Share
IVX INV102 (nadolol) presentation - status and milestones
16/06/15		1.06MB	Share
IVX Litigation update - Decision of Court of Appeal
12/06/15		228.81KB	Share
IVX Cleansing Notice - unlisted share options
28/05/15		214.62KB	Share
IVX Appendix 3B - unlisted share options to employees
28/05/15		501.5KB	Share
IVX Results of General Meeting
25/05/15		98.97KB	Share
IVX Drs Glass and Castro discuss data presented to ATS
19/05/15		232.79KB	Share
IVX Oral nadolol data presented to American Thoracic Society
19/05/15	PRICE SENSITIVE	241.73KB	Share
IVX Appendix 3B - correction to Rights Issue allotment number
11/05/15		768.95KB	Share
IVX Ceasing to be a substantial holder
04/05/15		45.34KB	Share
IVX Change in substantial holding
01/05/15		101.31KB	Share
IVX Appendix 4C - quarterly
29/04/15		229.42KB	Share
IVX Final Directors Interest Notice - Dr Ralph Craven
29/04/15		187.42KB	Share
IVX Invion appoints Mr Brett Heading as Chairman
29/04/15		221.96KB	Share
IVX Appendix 3Y - R Craven
28/04/15		281.83KB	Share
IVX Appendix 3Y - G Collier
28/04/15		283.32KB	Share
IVX Appendix 3Y - B Heading
28/04/15		282.86KB	Share
IVX Placement cleansing notice
27/04/15		229.63KB	Share
IVX Appendix 3B - Placement
27/04/15		506.26KB	Share
IVX Notice of General Meeting and sample Proxy Form (2)
24/04/15		771.49KB	Share
IVX Notice of General Meeting and sample Proxy Form (1)
24/04/15		705.07KB	Share
IVX Appendix 3B - Rights Issue new shares
24/04/15		506.23KB	Share
IVX Placement - additional information perLR 3.10.5A
22/04/15		211.78KB	Share
IVX Rights Issue fully subscribed- correction to issue price
22/04/15		228.22KB	Share
IVX Rights Issue fully subscribed
22/04/15		223.82KB	Share
IVX Rights Issue - short term BPAY code error and correction
16/04/15		215.84KB	Share
IVX Entitlement Offer - Notice of despatch
30/03/15		213.85KB	Share
IVX Entitlement offer - Letter to ineligible shareholders
30/03/15		254.09KB	Share
IVX Placement cleansing notice
27/03/15		229.92KB	Share
IVX Appendix 3B - Placement shares
27/03/15		505.25KB	Share
IVX Change in substantial holding
26/03/15		104.43KB	Share
IVX Appendix 3B
24/03/15		508.17KB	Share
IVX Pre-IND status for inhaled INV102 (nadolol)
23/03/15	PRICE SENSITIVE	242.11KB	Share
IVXPre-IND status for inhaled INV102 (nadolol)
23/03/15	PRICE SENSITIVE	242.11KB	Share
IVX Letter to eligible shareholders
20/03/15		274.59KB	Share
IVX Letter to option holders
20/03/15		221.14KB	Share
IVX Entitlment offer information booklet
20/03/15	PRICE SENSITIVE	2.63MB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change 0.004(4.17%)		Mkt cap ! $8.541M

Open	High	Low	Value	Volume
9.7¢	10.0¢	9.6¢	$6.613K	66.75K

Buyers (Bids)

No.	Vol.	Price($)
1	75887	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	294638	3

View Market Depth

No.	Vol.	Price($)
1	75887	0.096
2	60000	0.095
1	47000	0.094
1	25000	0.093
1	42667	0.092

Price($)	Vol.	No.
0.100	294638	3
0.105	22162	2
0.110	28153	1
0.115	58455	2
0.120	20233	2

Last trade - 15.14pm 30/07/2025 (20 minute delay)

IVX (ASX) Chart

INVION LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available